News and events

Welcome to Leigh Day's media centre. If you require an interview with one of our lawyers or would like more information on a story please contact our press team at pressoffice@leighday.co.uk or on 0161 393 3547.

If you are unable to get in touch with our press team, please contact our switchboard team on 020 7650 1200.

Recent news

• ​Union to take legal action on behalf of gig economy workers affected by coronavirus

  24 March 2020

  The Independent Workers’ Union of Great Britain (IWGB) has threatened legal action against the government, challenging its provisions for gig economy and low paid workers during the coronavirus outbreak.

• Sufferer of rare cancer takes legal action against manufacturers of Allergan breast implants

  23 March 2020

  A woman who had a double mastectomy in a bid to combat what she believed was her hereditary predisposition to breast cancer has had to accept that the breast implants with which her chest was reconstructed after the operation have caused her to develop a rare type of cancer associated specifically with breast implants.

• Employment concerns during the COVID-19 crisis

  20 March 2020

  Employers are currently facing uncharted waters following the significant impact on normal life in the face of COVID-19.

• ​Nursing home likely to face significant fine and claims for compensation following data breach

  20 March 2020

  A nursing home in Eastbourne is facing investigation after it was reported that documents detailing personal information of its disabled residents were found in the street.

• Former Bolton joiner receives settlement following asbestos-related diagnosis

  20 March 2020

  A former joiner from Bolton, Greater Manchester, has secured a settlement from his former employer following his diagnosis of asbestos-related cancer, mesothelioma.

• MHRA announces recall of drug Esmya due to risk of serious liver injury

  19 March 2020

  The Medicines and Healthcare Products Regulatory Agency (MHRA) has announced a recall of drug Esmya (ulipristal acetate) due to a risk of serious liver injury.